openPR Logo
Press release

Drug Repurposing Market Expected to Deliver Dynamic Progression until 2026 | Major Players GlaxoSmithKline, Atomwise, Biovista, Inc., Centene Corporation, NuMedii

10-22-2020 12:27 PM CET | Health & Medicine

Press release from: Allied Market Research

Drug Repurposing Market

Drug Repurposing Market

The global drug repurposing market experiences growth due to shorter drug development time for repurposed drugs compared to new chemical entities. In addition, advances in the computational power to process large databases has allowed cost-effective solutions to approach drug development. This further drives the growth of the market. However, limited understanding of polypharmaco logical effects of drugs and lack of trained personnel restrains the growth of the market. In contrast, increase in partnership of pharmaceutical companies among various academic research groups and startups to facilitate drug repurposing activities is anticipated to provide lucrative opportunities for the growth of the market.

Download Free Sample Report@ https://www.alliedmarketresearch.com/request-sample/6550

Drug Repurposing Market Competitive Analysis:

Leading market players Drug Repurposing market, Atomwise, Inc., Biovista, Inc., Centene Corporation (Health Net, LLC)NuMedii, Inc., Recursion Pharmaceuticals, Inc., SOM Innovation Biotech, S.L., Sosei Group Corporation (SoseiHeptares), Exscientia Limited, and Healx. Other players in the clue chain include Pfizer Inc., Johnson & Johnson, Sanofi, Astellas Pharma, GlaxoSmithKline plc,. others provided in this report. These players have adopted various strategies including expansions, mergers & acquisitions, joint ventures, new product launches, and collaborations to gain a strong position in the industry.

Covid-19 Impact on the Global Drug Repurposing Market:

Drug Repurposing Market Report provides an overview of the market based on key parameters such as market size, sales, sales analysis and key drivers. The market size of the market is expected to grow on a large scale during the forecast period (2019-2026). This report covers the impact of the latest COVID-19 on the market. The coronavirus epidemic (COVID-19) has affected all aspects of life around the world. This has changed some of the market situation. The main purpose of the research report is to provide users with a broad view of the market. Initial and future assessments of rapidly.

Get detailed COVID-19 impact analysis on the Drug Repurposing Market@ https://www.alliedmarketresearch.com/request-for-customization/6550?reqfor=covid

Drug Repurposing Market Segmentation:

The research offers a detailed segmentation of the global Drug Repurposing market. Key segments analyzed in the research,

By Therapeutic Area
• Oncology
• CNS Disorders
• Neurodegenerative Diseases
• Others

and geography. Extensive analysis of sales, revenue, growth rate, and market share of each for the historic period and the forecast period is offered with the help of tables.

Drug Repurposing Market Regional Analysis:

The market is analyzed based on regions and competitive landscape in each region is mentioned. Regions discussed in the study include North America (United States, Canada and Mexico), Europe (Germany, France, UK, Russia and Italy), Asia-Pacific (China, Japan, Korea, India and Southeast Asia), South America (Brazil, Argentina, and Colombia), Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa). These insights help to devise strategies and create new opportunities to achieve exceptional results.

Read More@ https://www.alliedmarketresearch.com/drug-repurposing-market-A06185

Contact:

David Correa
Portland, OR, United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com
Follow Us on LinkedIn: https://www.linkedin.com/company/allied-market-research

About Us:

Allied Market Research (AMR) is a market research and business-consulting firm of Allied Analytics LLP, based in Portland, Oregon. AMR offers market research reports, business solutions, consulting services, and insights on markets across 11 industry verticals. Adopting extensive research methodologies, AMR is instrumental in helping its clients to make strategic business decisions and achieve sustainable growth in their market domains. We are equipped with skilled analysts and experts, and have a wide experience of working with many Fortune 500 companies and small & medium enterprises.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Drug Repurposing Market Expected to Deliver Dynamic Progression until 2026 | Major Players GlaxoSmithKline, Atomwise, Biovista, Inc., Centene Corporation, NuMedii here

News-ID: 2168211 • Views:

More Releases from Allied Market Research

Food Minerals Market Giants Spending Is Going To Boom | $3 Billion by 2032
Food Minerals Market Giants Spending Is Going To Boom | $3 Billion by 2032
According to a new report published by Allied Market Research, titled, "Food Minerals Market," The food minerals market was valued at $1.6 billion in 2022, and is estimated to reach $3 billion by 2032, growing at a CAGR of 6.3% from 2023 to 2032. Request Sample PDF Of This Report: https://www.alliedmarketresearch.com/request-sample/A08416 Food minerals are essential for body development and the proper functioning of the body. Change in the food habits of consumers,
Biodegradable Cups Market is Expected to Rise $1.1 billion by 2031, Growing At a CAGR of 8.5% From 2023-2032
Biodegradable Cups Market is Expected to Rise $1.1 billion by 2031, Growing At a …
Rise in construction activities across various regions such as Europe & Asia-Pacific, surge in demand for innovative building designs, and increase in urbanization and industrialization in emerging economies are expected to drive the growth of the global architectural acoustic panels market. Closed manufacturing facilities, reduction in workforce, and other supply chain challenges during the COVID-19 pandemic had a negative impact on the growth of the market. The global architectural acoustic panels
Architectural Acoustic Panels Market is projected to achieve a value of $13.8 billion by 2031, reflecting a robust CAGR of 6.3%
Architectural Acoustic Panels Market is projected to achieve a value of $13.8 bi …
Rise in construction activities across various regions such as Europe & Asia-Pacific, surge in demand for innovative building designs, and increase in urbanization and industrialization in emerging economies are expected to drive the growth of the global architectural acoustic panels market. Closed manufacturing facilities, reduction in workforce, and other supply chain challenges during the COVID-19 pandemic had a negative impact on the growth of the market. Download Sample PDF (255 Pages
Nanosatellite and Microsatellite Market Demand, leading global Companies and Regional Average Pricing Analysis by 2030
Nanosatellite and Microsatellite Market Demand, leading global Companies and Reg …
𝐍𝐚𝐧𝐨𝐬𝐚𝐭𝐞𝐥𝐥𝐢𝐭𝐞 𝐚𝐧𝐝 𝐌𝐢𝐜𝐫𝐨𝐬𝐚𝐭𝐞𝐥𝐥𝐢𝐭𝐞 𝐌𝐚𝐫𝐤𝐞𝐭 by End User (Civil, Government, Commercial, and Military), Application (Communications, Earth Observation, Space Science, Technology Demonstration, and Technology Development), and Orbit Type (Non-Polar Inclined, Polar, and Sun-Synchronous): Global Opportunity Analysis and Industry Forecast, 2021-2030." As per the report, the global nanosatellite and microsatellite industry was accounted for $2.23 billion in 2020, and is expected to reach $8.69 billion by 2030, growing at a CAGR of 14.9%

All 5 Releases


More Releases for Drug

Alcohol Testing And Drug Testing Equipment Market 2025 Segmentation, Application …
Market Study Report, LLC, has compiled an exhaustive research study of the ‘Alcohol Testing And Drug Testing Equipment market’, detailing every single market driver and intricately analyzing the business vertical. This ‘Alcohol Testing And Drug Testing Equipment market’ study will aid in seeking out new business opportunities and fine-tuning existing marketing strategies through insights regarding SWOT analysis, market valuation, competitive spectrum, regional share, and revenue predictions. Alcohol abuse and drug
How much Diabetes Drug Market Impact Worldwide Medical Drug Industry?
Diabetes Drug Market From an insight perspective, the market report focuses on various levels of analyses — industry analysis, market rank analysis, and company profiles, which together comprise and discuss basic views on the competitive landscape, high-growth regions, and countries as well as their respective regulatory policies, Types ,Applications and opportunities in the market.  Diabetes is a metabolic disorder in which the body glucose level is elevated. There are two types of diabetes
Hepatitis Drug Market Hepatitis Drug Clinical Pipeline Report 2023
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents 1. Introduction to Hepatitis Disease 1.1 Prologue 1.1.1 History of Hepatitis 1.1.2 Causes of Hepatitis Disease 1.2 Types of Viruses which are Responsible for Hepatitis Disease 2. Global Prevalence of Hepatitis Infection 3. Available Drug Classes for Hepatitis Disease Treatment 3.1 Interferon Alfa Therapy 3.2 Protease Inhibitors Therapy 3.3 Polymerase
Microcapsules Drug Delivery Market Microcapsules Drug Delivery Sales Report 2022
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents 1. Indispensable Advent of Microcapsules 1.1 Trajectory of Microencapsulation 1.2 Why and wherefores for Microencapsulation 2. Characterization of Microcapsules 2.1 Composition of Microcapsules 2.2 Parameters Influencing Microcapsules 3. Engineering Technology of Microcapsules 3.1 Physical Manufacturing Technologies 3.2 Physicochemical and Chemical Technologies 4. Applicability of Microcapsules 4.1 Microcapsules in Pharmaceuticals 4.2 Microcapsules in Nutraceuticals
AstraZeneca’s NMOSD Drug receives orphan drug designation
April 18, 2017 Orphan Drug European Medicine Agency has Announced orphan drug designation for inebilizumab (earlier known as MEDI-551) developed by AstraZeneca PLC (AZN) for the treatment of neuromyelitis optica spectrum disorder (NMOSD). The drug has already received orphan drug status from US Food and Drug Administration (FDA). NMOSD, also called Devic’s disease, is a rare, autoimmune disorder of the central nervous system (CNS) that affects the functioning
Drug Discovery Strategies, PBPK Modeling and Drug-Drug Interaction Explored and …
This year’s 12th annual ADMET conference and exhibition promises to deliver appearances from experienced pharmaceutical professionals from ADME and PK/PD organisations such as AbbVie, GSK, Roche and Bayer when it returns to London this June. The carefully selected speaker line up will be addressing early ADME application strategies and discussing the latest technologically advanced screening and testing models along with exploring ADMET technologies which will identify properties of a drug